Comparison of Breast Cancer Risk Predictive Models and Screening Strategies for Chinese Women

Journal of Women's Health

Volumn 26, Issue 3, 2017, Pages 294-302

  Zhao, Ying ^a,e   Xiong, Ping ^a   McCullough, Lauren E ^b,c   Miller, Erline E ^b   Li, Hui ^a   Huang, Yuan ^a,d   Zhao, Min ^a   Wang, Meng Jie ^a   Kang, Min ^f   Wang, Qiong ^a,g   Li, Jia Yuan ^a  

^a SICHUAN UNIVERSITY   (China)

^b University of North Carolina at Chapel Hill   (United States)

^c EMORY UNIVERSITY   (United States)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^e SICHUAN UNIVERSITY   (China)

^f Women's and Children's Hospital of Sichuan Province   (China)

^g SUN YAT SEN UNIVERSITY   (China)

Author keywords

artificial neural network; breast cancer; mammography; risk assessment; screening

Indexed keywords

ADULT; AGED; ARTICLE; ARTIFICIAL NEURAL NETWORK; BACK PROPAGATION; BREAST BIOPSY; BREAST CANCER; CANCER RISK; CANCER SCREENING; CHINESE; COST EFFECTIVENESS ANALYSIS; CROSS-SECTIONAL STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FIRST-DEGREE RELATIVE; FOLLOW UP; GAIL MODEL; GROUPS BY AGE; HIGH RISK POPULATION; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MAMMOGRAPHY SYSTEM; MATHEMATICAL MODEL; PATIENT SELECTION; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; YOUDEN INDEX; AGE; BODY MASS; BREAST NEOPLASMS; CHINA; COST BENEFIT ANALYSIS; EARLY CANCER DIAGNOSIS; MASS SCREENING; MIDDLE AGED; PROCEDURES; REPRODUCTIVE HISTORY; RISK FACTOR; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; THEORETICAL MODEL;

ADULT; AGE FACTORS; AGED; BODY MASS INDEX; BREAST NEOPLASMS; CHINA; COST-BENEFIT ANALYSIS; CROSS-SECTIONAL STUDIES; EARLY DETECTION OF CANCER; FEMALE; HUMANS; LOGISTIC MODELS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; MODELS, THEORETICAL; REPRODUCTIVE HISTORY; RISK FACTORS;

EID: 85015734396     PISSN: 15409996     EISSN: 1931843X     Source Type: Journal    
DOI: 10.1089/jwh.2015.5692     Document Type: Article

References (46)

1. Tao ZQ, Shi A, Lu C, Song T, Zhang Z, Zhao J. Breast Cancer: Epidemiology and etiology. Cell Biochem Biophys 2015;72:333-338.
2. Cheng WQ, Zhang SW, Zeng HM. Report of cancer incidence and mortality in China 2010. China Cancer 2014; 23:1-10.
3. Li J, Zhang BN, Fan JH, Pang Y, Zhang P, Wang SL, et al. A nation-wide multicenter 10-year (1999-2008) retrospective clinical epidemiological study of female breast cancer in China. BMC Cancer 2011;11:364.
4. Song QK, Li J, Huang R, Fan J, Zheng R, Zhang B. Age of diagnosis of breast cancer in china: Almost 10 years earlier than in the United States and the European union. Asian Pac J Cancer Prev 2014;15:10021-10025.
5. Shapiro S, Coleman EA, Broeders M, Codd M, de Koning H, Fracheboud J, et al. Breast cancer screening programmes in 22 countries: Current policies, administration and guidelines. International Breast Cancer Screening Network (IBSN) and the European Network of Pilot Projects for Breast Cancer Screening. Int J Epidemiol 1998;27:735-742.
6. Humphrey LL, Helfand M, Chan BK, Woolf SH. Breast cancer screening: A summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2002;137: 347-360.
7. Uchida K, Yamashita A, Kawase K, Kamiya K. Screening ultrasonography revealed 15% of mammographically occult breast cancers. Breast Cancer 2008;15:165-168.
8. Huang Y, Kang M, Li H, Li JY, Zhang JY, Liu LH, et al. Combined performance of physical examination, mammography, and ultrasonography for breast cancer screening among Chinese women: A follow-up study. Curr Oncol 2012; 19:22-30.
9. Wong IO, Kuntz KM, Cowling BJ, Lam CL, Leung GM. Cost effectiveness of mammography screening for Chinese women. Cancer 2007;110:885-895.
10. Leung GM, Lam T.H, Thach TQ, Hedley AJ. Will screening mammography in the East do more harm than good? Am J Public Health 2002;92:1841-1846.
11. Evans DG, Howell A. Breast cancer risk-assessment models. Breast Cancer Res 2007;9:213.
12. Amir E, Freedman OC, Seruga B, Evans DG. Assessing women at high risk of breast cancer: A review of risk assessment models. J Natl Cancer Inst 2010;102:680.
13. Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Schairer C, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 1989;81:1879-1886.
14. Antoniou AC, Durocher F, Smith P, Simard J, Easton DF. BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families. Breast Cancer Res 2006;8:R3.
15. Rao NY. Research on genetic susceptibility of Han Chinese breast cancer patients. Shanghai: Fudan University, 2008 (in Chinese).
16. Christine SP, Jorge CO, Jonathan LP, Annette SG. Risk factors for breast cancer in East Asian women relative to women in the West. Asia Pac J Clin Oncol 2009;5:219-231.
17. Li ZD, Cheng XL, Fu Y, Jiang PQ, Zhuang ZG. Preliminary study on risk assessment model of breast cancer in Shanghai. Mod Oncol 2012;20:2293-2296 (in Chinese).
18. Pan XP, Jin X, Ding H, WANG Q, Liu L, Qi XD, et al. Preliminary study on risk evaluation model of breast cancer in Beijing and Guangdong. Mater Child Health Care China 2009;24:1469-1471 (in Chinese).
19. Lee H, Li JY, Fan Jh, Li J, Huang R, Zhang BN. Risk factors for breast cancer among Chinese women: A 10-year nationwide multicenter cross-sectional study. J Epidemiol 2014;24:67-76.
20. Wang Q, Li H, Tao P, Wang YP, Yuan P, Yang CX, et al. Soy isoflavones, CYP1A1, CYP1B1, and COMT polymorphisms, and breast cancer: A case-control study in southwestern China. DNA Cell Biol 2011;30:585-595.
21. ACR. BI-RADS-mammography: Breast imaging reporting and data system, breast imaging atlas. Preston: ACR, 2003.
22. Zonderland HM, Pope TL, Nieborg AJ. The positive predictive value of the breast imaging reporting and data system (BIRADS) as a method of quality assessment in breast imaging in a hospital population. Eur Radiol 2004;14:1743-1750.
23. Tang ZH, Liu J, Zeng F, Lam T. Comparison of prediction model for cardiovascular autonomic dysfunction using artificial neural network and logistic regression analysis. PLoS One 2013;8:e70571.
24. Lugade V, Lin V, Farley A, Chou LS. An artificial neural network estimation of gait balance control in the elderly using clinical evaluations. PLoS One 2014;9:e97595.
25. Huang ZZ, Chen WQ, Wu CX, Zheng RS, Chen JG, Yang NN, et al. Incidence and mortality of female breast cancer in China-a report from 32 Chinese cancer registries, 2003-2007. Tumor 2012;32:435-439 (in Chinese).
26. Altman DG, Bland JM. Diagnostic tests 2: Predictive values. BMJ 1994;309:102.
27. Suga K, Imai K, Eguchi H, Hayashi S, Higashi Y, Nakachi K. Molecular significance of excess body weight in postmenopausal breast cancer patients, in relation to expression of insulin-like growth factor I receptor and insulin-like growth factor II genes. Jpn J Cancer Res 2001;92:127-134.
28. Tao P, Hu YY, Huang Y, Li JY. Risk factors of breast cancer in Asian women: A meta-analysis. Chin J Epidemiol 2011;32:164-169 (in Chinese).
29. Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004;89:2548-2556.
30. Arcidiacono B, Iiritano S, Nocera A, Possidente K, Nevolo MT, Ventura V, et al. Insulin resistance and cancer risk: An overview of the pathogenetic mechanisms. Exp Diabetes Res 2012;2012:789174.
31. Santen RJ, Yue W, Wang JP. Estrogen metabolites and breast cancer. Steroids 2015;99:61-66.
32. Russo J, Balogh GA, Heulings R, Mailo DA, Moral R, Russo PA, et al. Molecular basis of pregnancy-induced breast cancer protection. Euro J Cancer Prev 2006;15:306-342.
33. Frazier AL, Rosenberg SM. Preadolescent and adolescent risk factors for benign breast disease. J Adolesc Health 2013;52:S36-S40.
34. Dorjgochoo T, Deming SL, Gao YT, Lu W, Zheng Y, Ruan ZX, et al. History of benign breast disease and risk of breast cancer among women in China: A case-control study. Cancer Causes Control 2008;18:819-828.
35. Colditz GA, Hankinson SE, Hunter DJ, Willett WC, Manson JE, Stampfer MJ, et al. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med 1995;332:1589-1593.
36. Albini A, Rosano C, Angelini G, Amaro A, Esposito AI, Maramotti S, et al. Exogenous hormonal regulation in breast cancer cells by phytoestrogens and endocrine disruptors. Curr Med Chem 2014;21:1129-1145.
37. Gao YT, Shu XO, Dai Q, Potter JD, Brinton LA, Wen W, et al. Association of menstrual and reproductive factors with breast cancer risk: Results from the Shanghai Breast Cancer Study. Int J Cancer 2000;87:295-300.
38. Jiang AR, Gao CM, Ding JH, Li SP, Liu YT, Cao HX, et al. Abortions and breast cancer risk in premenopausal and postmenopausal women in Jiangsu Province of China. Asian Pac J Cancer Prev 2012;13:33-35.
39. Anders K. What are artificial neural networks. Nat Biotechnol 2008;26:195-197.
40. Ayer T, Chhatwal J, Alagoz O, Kahn CE, Jr., Woods RW, Burnside ES. Informatics in radiology: Comparison of logistic regression and artificial neural network models in breast cancer risk estimation. Radiographics 2010;30: 13-22.
41. Zhou SH, Nie SF, Wang CJ, Wei S, Xu YH, Li XH, et al. The application of artificial neural networks to predict individual risk of essential hypertension. Chin J Epidemiol 2008;29:614-617 (in Chinese).
42. Liu Y, Li R, Huang J, Zhao W. Evaluation on effect of two screening models for diabetes. J Environ Occup Med 2010;27:127-130 (in Chinese).
43. Biglarian A, Bakhshi E, Gohari MR, Khodabakhshi R. Artificial neural network for prediction of distant metastasis in colorectal cancer. Asian Pac J Cancer Prev 2012;13:927-930.
44. Sankaranarayanan R, Ramadas K, Thara S, Muwonge R, Prabhakar J, Augustine P, et al. Clinical breast examination: Preliminary results from a cluster randomized controlled trial in India. J Natl Cancer Inst 2011;103:1476-1480.
45. WHO. National cancer control programmes: Policies and managerial guidelines. Geneva, Switzerland: World Health Organization, 2002.
46. Tu JV. Advantages and disadvantages of using artificial neural networks versus logistic regression for predicting medical outcomes. J Clin Epidemiol 1996;49:1225-1231.